Total Payments
$197,008
2024 Payments
$17,702
Companies
21
Transactions
801
Medicare Patients
14,826
Medicare Billing
$1.3M
Payment Breakdown by Category
Consulting$124,397 (63.1%)
Other$53,481 (27.1%)
Food & Beverage$15,729 (8.0%)
Travel$3,382 (1.7%)
Education$18.52 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $124,397 | 186 | 63.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $50,100 | 19 | 25.4% |
| Food and Beverage | $15,729 | 576 | 8.0% |
| Travel and Lodging | $3,382 | 15 | 1.7% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,932 | 2 | 1.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,449 | 1 | 0.7% |
| Education | $18.52 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $135,443 | 418 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $52,559 | 100 | $0 (2024) |
| Medtronic Vascular, Inc. | $2,675 | 50 | $0 (2020) |
| Boston Scientific Corporation | $1,723 | 47 | $0 (2024) |
| Biosense Webster, Inc. | $1,459 | 50 | $0 (2024) |
| Medtronic, Inc. | $1,032 | 40 | $0 (2024) |
| BIOTRONIK INC. | $566.58 | 22 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $471.13 | 28 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $440.97 | 23 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $187.37 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,702 | 77 | Abbott Laboratories ($16,613) |
| 2023 | $6,987 | 59 | Abbott Laboratories ($6,134) |
| 2022 | $5,467 | 76 | Abbott Laboratories ($4,152) |
| 2021 | $31,742 | 102 | Abbott Laboratories ($30,902) |
| 2020 | $17,255 | 98 | Abbott Laboratories ($9,886) |
| 2019 | $40,945 | 107 | Janssen Pharmaceuticals, Inc ($20,478) |
| 2018 | $36,922 | 139 | Abbott Laboratories ($24,758) |
| 2017 | $39,988 | 143 | Abbott Laboratories ($24,996) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/19/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $36.28 | General |
| Category: Cardiology | ||||||
| 12/18/2024 | Abbott Laboratories | ALLURE (Device) | Consulting Fee | Cash or cash equivalent | $495.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/17/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $47.26 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 11/01/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $47.00 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 10/08/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/03/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $49.21 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Ablation | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/30/2024 | Abbott Laboratories | TENDRIL (Device) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/20/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Pacemakers | ||||||
| 08/06/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Pacemakers | ||||||
| 08/02/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $36.21 | General |
| Category: Cardiology | ||||||
| 08/01/2024 | Abbott Laboratories | ACCENT (Device) | Consulting Fee | Cash or cash equivalent | $495.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/01/2024 | Abbott Laboratories | ACCENT (Device) | Consulting Fee | Cash or cash equivalent | $495.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/01/2024 | Abbott Laboratories | ACCENT (Device) | Consulting Fee | Cash or cash equivalent | $495.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/01/2024 | Abbott Laboratories | ACCENT (Device) | Consulting Fee | Cash or cash equivalent | $495.00 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/01/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/23/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $68.70 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/08/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/03/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 3,769 | 7,163 | $522,213 | $348,884 |
| 2022 | 44 | 3,681 | 6,305 | $460,509 | $315,020 |
| 2021 | 49 | 3,543 | 5,603 | $478,565 | $336,395 |
| 2020 | 44 | 3,833 | 5,930 | $472,367 | $329,304 |
Total Patients
14,826
Total Services
25,001
Medicare Billing
$1.3M
Procedure Codes
187
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 500 | $67,102 | $50,345 | 75.0% |
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 14 | 14 | $68,340 | $49,073 | 71.8% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 32 | 32 | $36,987 | $24,308 | 65.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 145 | 787 | $29,232 | $22,473 | 76.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 178 | 816 | $23,071 | $16,206 | 70.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 113 | 121 | $25,323 | $15,920 | 62.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 312 | 767 | $20,392 | $12,840 | 63.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 203 | 221 | $20,957 | $11,973 | 57.1% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 17 | 17 | $15,659 | $10,776 | 68.8% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 16 | 16 | $16,394 | $10,647 | 64.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 82 | 82 | $15,521 | $10,286 | 66.3% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 39 | 39 | $13,680 | $9,752 | 71.3% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 169 | 426 | $15,038 | $9,378 | 62.4% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 145 | 342 | $23,634 | $9,255 | 39.2% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 12 | 12 | $12,479 | $8,926 | 71.5% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 32 | 32 | $11,199 | $8,002 | 71.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 52 | 383 | $10,969 | $7,758 | 70.7% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 18 | 18 | $10,608 | $7,508 | 70.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 79 | $8,545 | $6,701 | 78.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 302 | 485 | $7,266 | $5,011 | 69.0% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 293 | 461 | $6,094 | $4,226 | 69.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 77 | 78 | $5,983 | $3,810 | 63.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 102 | 136 | $5,734 | $3,684 | 64.2% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 64 | 82 | $5,441 | $3,653 | 67.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 64 | $4,804 | $3,140 | 65.4% |
About Dr. Alexander Drtil, MD
Dr. Alexander Drtil, MD is a Cardiovascular Disease healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1942294715.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Drtil, MD has received a total of $197,008 in payments from pharmaceutical and medical device companies, with $17,702 received in 2024. These payments were reported across 801 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($124,397).
As a Medicare-enrolled provider, Drtil has provided services to 14,826 Medicare beneficiaries, totaling 25,001 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Houston, TX
- Active Since 09/07/2005
- Last Updated 10/05/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1942294715
Products in Payments
- XARELTO (Drug) $52,746
- Accent Pacemaker (Device) $17,370
- Quadra Assura CRT Defibrillator (Device) $14,273
- ACCENT (Device) $13,118
- Fortify Assura, Ellipse ICD (Device) $11,933
- EnSite Precision Cardiac Mapping System (Device) $11,662
- GALLANT (Device) $11,659
- CRT-Ps (Device) $9,930
- Allure Quadra RF CRT Pacemaker (Device) $7,245
- Assurity Pacemaker (Device) $6,596
- Irrigated Ablation Catheters (Device) $4,800
- Pacemakers (Device) $4,788
- CRT-Ds (Device) $4,430
- ICDs (Device) $4,111
- Ensite Cardiac Mapping System (Device) $2,516
- Quadra Allure MP RF CRT Pacemkr (Device) $2,404
- EP-WorkMate Claris System (Device) $2,000
- Micra (Device) $1,861
- Allure CRT Pacemaker (Device) $1,328
- AVEIR (Device) $1,282
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Houston
Reynolds Delgado, M.d, M.D
Cardiovascular Disease — Payments: $600,466
Cardiovascular Disease $600,466
Dr. Miguel Valderrabano, Md, MD
Cardiovascular Disease — Payments: $471,736
Cardiovascular Disease $471,736
Asif Ali, Md, MD
Cardiovascular Disease — Payments: $461,190
Cardiovascular Disease $461,190
Mr. Mehdi Razavi, Md, MD
Cardiovascular Disease — Payments: $433,792
Cardiovascular Disease $433,792
Dr. Michele Sartori, M.d, M.D
Cardiovascular Disease — Payments: $278,682
Cardiovascular Disease $278,682
Barry Trachtenberg, Md, MD
Cardiovascular Disease — Payments: $273,547
Cardiovascular Disease $273,547